journal article·2022-11-13Open access

COVID-19 and Clinically Isolated Syndrome: Coincidence or Causative Link? A 12-Month Follow-Up Case Report

Davide Romano, Antonella Macerollo, Giuseppe Giannaccare, Daniela Mazzuca, Alfredo Borgia, Vito Romano, Francesco Semeraro, Richard Ellis

Applied Sciences· Volume 12· Issue 22

Abstract

A 35-year-old female with positive anamnesis of COVID-19 infection presented with a seven-day history of headache along with tingling and numbness involving the right lower limb and visual disturbance on the right side of her vision. Magnetic resonance imaging (MRI) of the brain and C-spine were consistent with acute demyelinating lesions. However, the MAGNIMS criteria for a multiple sclerosis diagnosis were not met, and, subsequently, a diagnosis of clinically isolated syndrome (CIS) was made. At 12 months, the patient showed new inflammatory lesions in the right frontal lobe and at the septocallosal interface, a lesion of the right hemi-cord at C3, and subsequent development of vertigo and unsteadiness and signs consistent with a brainstem/cerebellar relapse. On the basis of clinical and radiological criteria in the 2017 McDonald criteria, a diagnosis of relapsing remitting multiple sclerosis was made.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Long-Term Effects of COVID-19 · Retinal and Optic Conditions · Multiple Sclerosis Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Eye Clinic, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, 25121 Brescia, Italy

St. Paul’s Eye Unit, Royal Liverpool University Hospital, Liverpool L7 8XP, UK

Institute of Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 3BX, UK

Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool L9 7LJ, UK

Department of Ophthalmology, University ‘Magna Græcia’ of Catanzaro Viale Europa, 88100 Germaneto, Italy

Department of Surgical and Medical Sciences, University ‘Magna Græcia’ of Catanzaro, Viale Europa, 88100 Germaneto, Italy

References (26)

Show source-provided references
1. Neurological manifestations of coronavirus disease 2019: Exploring past to understand present10.1007/s10072-020-04964-8 ↗
2. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: A review10.1001/jamaneurol.2020.2065 ↗
3. Neurological associations of COVID-1910.1016/S1474-4422(20)30221-0 ↗
4. COVID-19 AdenoviralVector Vaccine and Central Retinal Vein Occlusion10.1080/09273948.2022.2079534 ↗
5. Nervous System Involvement in COVID-19: A Review of the Current Knowledge10.1007/s12035-021-02347-4 ↗
6. Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis10.1017/cjn.2020.146 ↗
7. Multiple sclerosis following SARS-CoV-2 infection10.1016/j.msard.2020.102377 ↗
8. A first presentation of multiple sclerosis with concurrent COVID-19 infection10.1016/j.ensci.2020.100299 ↗
9. Demyelinating Changes Alike to Multiple Sclerosis: A Case Report of Rare Manifestations of COVID-19
10. A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis10.1016/j.autrev.2021.102803 ↗
11. A case report of multiple sclerosis after COVID-19 infection: Causality or coincidence?10.1016/j.nerep.2021.100008 ↗
12. Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?10.3389/fimmu.2021.755333 ↗
13. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination10.1007/s40263-020-00756-y ↗
14. Multiple Sclerosis Following SARS-CoV-2 Infection: A Case Report and Literature Review
15. Infectious causes of multiple sclerosis10.1016/S1474-4422(05)70023-5 ↗
16. The role of infections in multiple sclerosis10.1177/1352458518823940 ↗
17. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis10.1126/science.abj8222 ↗
18. Epstein-Barr Virus and Multiple Sclerosis10.3389/fimmu.2020.587078 ↗
19. Evidence linking HHV-6 with multiple sclerosis: An update10.1016/j.coviro.2014.09.016 ↗
20. Lifting the mask on neurological manifestations of COVID-1910.1038/s41582-020-0398-3 ↗
21. The pathogenesis of murine coronavirus infection of the central nervous system10.1615/CritRevImmunol.v30.i2.20 ↗
22. Detection of coronavirus RNA and antigen in multiple sclerosis brain10.1002/ana.410310511 ↗
23. Human coronavirus gene expression in the brains of multiple sclerosis patients10.1016/0042-6822(92)90220-J ↗
24. COVID-19, SARS and MERS: Are they closely related?10.1016/j.cmi.2020.03.026 ↗
25. Neuroinvasive and neurotropic human respiratory coronaviruses: Potential neurovirulent agents in humans10.1007/978-81-322-1777-0_6 ↗
26. Körner, R.W., Majjouti, M., Alcazar, M.A.A., and Mahabir, E. (2020). Of mice and men: The coronavirus mhv and mouse models as a translational approach to understand SARS-CoV-2. Viruses, 12.10.3390/v12080880 ↗